IRIS
CAMPIONE, ELENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.822
EU - Europa 3.028
AS - Asia 1.719
SA - Sud America 15
OC - Oceania 14
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 11
Totale 36.620
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.787
SG - Singapore 1.022
IT - Italia 741
IE - Irlanda 509
CN - Cina 456
DE - Germania 344
UA - Ucraina 321
RU - Federazione Russa 306
FR - Francia 190
SE - Svezia 172
GB - Regno Unito 157
PL - Polonia 96
FI - Finlandia 94
KR - Corea 94
BE - Belgio 34
IN - India 28
JP - Giappone 21
CA - Canada 19
UZ - Uzbekistan 17
HK - Hong Kong 16
KG - Kirghizistan 15
MX - Messico 14
ES - Italia 13
AU - Australia 12
NL - Olanda 12
BR - Brasile 10
CZ - Repubblica Ceca 10
EU - Europa 10
IL - Israele 10
VN - Vietnam 10
EG - Egitto 7
IR - Iran 7
RO - Romania 7
AT - Austria 5
ID - Indonesia 5
MY - Malesia 5
GR - Grecia 3
NO - Norvegia 3
PT - Portogallo 3
TH - Thailandia 3
TR - Turchia 3
AR - Argentina 2
DK - Danimarca 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PA - Panama 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MA - Marocco 1
MU - Mauritius 1
NG - Nigeria 1
PE - Perù 1
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 36.620
Salva come PNG Salva come JPEG
Città #
Wilmington 8.797
Houston 8.228
Woodbridge 6.847
Fairfield 1.431
Singapore 903
Chandler 766
Ashburn 666
Seattle 610
Ann Arbor 539
Cambridge 500
Dublin 460
Medford 326
Rome 293
Jacksonville 272
Santa Clara 216
Dearborn 194
Beijing 177
New York 167
Lawrence 156
San Diego 114
Zhengzhou 102
Menlo Park 96
Kraków 90
Moscow 66
Boardman 60
Redwood City 46
Milan 44
Munich 41
Seoul 40
Brussels 31
London 30
Cedarhurst 28
Mülheim 28
Falls Church 24
Helsinki 24
Nanjing 23
Norwalk 21
Shanghai 21
Nuremberg 19
Council Bluffs 18
Del Norte 18
Palo Alto 17
Atlanta 16
Hefei 15
Los Angeles 15
Naples 15
Toronto 15
Verona 15
Engelhard 14
Guangzhou 14
Detroit 12
San Mateo 12
Mountain View 11
University Park 11
Brno 10
Kilburn 10
Esslingen am Neckar 9
Jinan 9
Lappeenranta 9
Nanchang 9
Salt Lake City 9
Creede 8
Manitou Springs 8
Redmond 8
São Paulo 8
Wuhan 8
Dong Ket 7
Kunming 7
Madrid 7
Petah Tikva 7
Phoenix 7
Saint Petersburg 7
The Dalles 7
Cairo 6
Chicago 6
Sydney 6
Tokyo 6
Turin 6
Aprilia 5
Auburn Hills 5
Bologna 5
Hangzhou 5
Indiana 5
Kuala Lumpur 5
Mexico City 5
Paris 5
Pune 5
San Jose 5
Viterbo 5
Ancona 4
Augusta 4
Center 4
Central 4
Chongqing 4
Frankfurt am Main 4
Fuzhou 4
Hackensack 4
Hong Kong 4
Marana 4
Monterrey 4
Totale 32.997
Salva come PNG Salva come JPEG
Nome #
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.178
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors 713
Loss of CRABP-II Characterizes Human Skin Poorly Differentiated Squamous Cell Carcinomas and Favors DMBA/TPA-Induced Carcinogenesis 656
Dermoscopic monitoring of efficacy of Ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas 588
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 441
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 435
Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial 432
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 420
Tazarotene as alternative topical treatment for onychomycosis 417
Pyoderma gangrenosum in refractory celiac disease: a case report 415
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 414
CNS and cutaneous involvement in patients with chronic myeloid leukemia treated with imatinib in hematologic complete remission: two case reports. 412
Actinic keratosis treated with an immune response modifier: a case report of six patients 411
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 399
Agminated Dermal Melanocytosis in the Territory of Ota's Nevus 398
Severe erytrodermic psoriasis and arthritis as clinical presentation of a CARD14-mediated psoriasis (CAMPS) 397
Fungistatic activity of all-trans retinoic acid against Aspergillus fumigatus and Candida albicans 393
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 391
Severe acne successfully treated with etanercept 384
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 384
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 383
Type I lamellar ichthyosis improved by tazarotene 0.1% gel 383
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 381
Cutaneous features of myotonic dystrophy types 1 and 2: implication of premature aging and vitamin d homeostasis 375
Connexin 26 (GJB2) mutations, causing KID Syndrome, are associated with cell death due to calcium gating deregulation 370
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 369
Novel transglutaminase 1 mutations in patients affected by lamellar ichthyosis 363
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 362
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 360
Bilateral Thoracoscopic T2 to T3 Sympathectomy Versus Botulinum Injection in Palmar Hyperhidrosis 360
Sequential molecular analysis of circulating MCAM/MUC18 expression: a promising disease biomarker related to clinical outcome in melanoma 359
Confocal reflectance microscopy in pityriasis rubra pilaris 359
The efficacy and tolerability of 5-aminolevulinic acid 5% thermosetting gel photodynamic therapy (PDT) in the treatment of mild-to-moderate acne vulgaris. A two-center, prospective assessor-blinded, proof-of-concept study 355
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 354
Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146 342
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 341
Expression and potential role of cellular retinol binding protein I in psoriasis 340
Connexin 26 (GJB2) mutations as a cause of the KID syndrome with hearing loss 338
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 335
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 335
Pyoderma vegetans and ulcerative colitis 334
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 334
Blood MUC-18/MCAM expression in patients with melanoma: A suitable marker of poor outcome 333
Immunologic biomarkers for clinical and therapeutic management of psoriasis 332
New insight into the pathogenesis of nail psoriasis and overview of treatment strategies 332
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 328
Dermatomyositis associated with ovarian transitional cell carcinoma 327
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 325
Cerebral cavernomas in a family with multiple cutaneous and uterine leiomyomas associated with a new mutation in the fumarate hydratase gene J Invest Dermatol. 2007 Sep;127(9):2271-3. 320
Analysis of risk factors in cutaneous malignant melanoma: an italian population-based study 320
Treatment of Multiple Actinic Keratosis and Field of Cancerization with Topical Piroxicam 0.8% and Sunscreen 50+ in Organ Transplant Recipients: A Series of 10 Cases 319
Nodular morphea in a patient with Steinert disease 318
Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy 315
Imiquimod for restoring local immunity in a renal transplant patient with persistent keratoacanthoma 314
A safety evaluation of guselkumab for the treatment of psoriasis 311
Acute onset disseminated superficial porokeratosis heralding diffuse large B-cell lymphoma 310
Current developments in pharmacotherapy for actinic keratosis 307
A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab 303
High-dose Intravenous Immunoglobulin for Severe Drug Reactions: Efficacy in Toxic Epidermal Necrolysis 300
Kruppel-like factor 4 regulates keratinocyte senescence 300
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics 299
Progressive late-onset of cutaneous angiomatosis as possible sign of cerebral cavernous malformations 297
Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and cerebral cavernomas 296
Monitoring treatment response in patients affected by actinic keratosis: Dermoscopic assessment and metalloproteinases evaluation after piroxicam 0.8% and sunfilter cream 294
Electrochemotherapy for basocellular and squamocellular head and neck cancer: preliminary experience in day surgery unit. 288
Biomolecular index of therapeutic efficacy in psoriasis treated by anti-TNF alpha agents. 277
Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy 269
Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution 259
Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review 258
Nails as immune-privileged sites: A case of disabling Acrodermatitis continua of Hallopeau successfully treated with Apremilast 256
Efficacy of sinecatechins 10% as proactive sequential therapy of external genital warts after laser CO2 ablative therapy: The PACT study (post-ablation immunomodulator treatment of condylomata with sinecatechins): a randomized, masked outcome assessment, multicenter trial 246
Non-familial porphyria cutanea tarda: a case report of a rare disease 244
Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial 243
Bednar Tumour Occurring after Malignant Melanoma Excision 242
Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2 241
Relation between animal-type melanoma and reduced nuclear expression of glutathione S-transferase pi 240
Effects of a cream containing 5% hyaluronic acid mixed with a bacterial-wall-derived glycoprotein, glycyrretinic acid, piroctone olamine and climbazole on signs, symptoms and skin bacterial microbiota in subjects with seborrheic dermatitis of the face 229
Investigational drugs currently in phase II clinical trials for actinic keratosis 229
Apremilast efficacy and safety in a psoriatic arthritis patient affected by HIV and HBV virus infections 227
Potential of Curcumin in Skin Disorders 225
Skin immunity and its dysregulation in psoriasis 222
Drug-induced lichen planus pigmentosus: Do supportive and complementary drugs count? 219
Therapeutic monitoring of male genital lichen sclerosus: usefulness of reflectance confocal microscopy 216
Birt–Hogg–Dubé syndrome, from non-invasive dermatologic assessment to gene testing, molecular and ultrastructural histologic analysis 210
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast 209
Sofosbuvir induced leucocytoclasic vasculitis: a case report 202
New local treatment for photoaging using a formulation containing piroxicam 0.8% and sunscreen 190
Clinical evidence on the efficacy and tolerability of a topical medical device containing benzoylperoxide 4%, retinol 0.5%, mandelic acid 1% and lactobionic acid 1% in the treatment of mild facial acne: An open label pilot study 183
Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice 180
Transglutaminase 3 is expressed in basal cell carcinoma of the skin 178
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives 174
Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo 171
The E3 ligase Itch knockout mice show hyperproliferation and wound healing alteration 171
Cellular retinoic acid binding protein-II expression and its potential role in skin aging 170
Luteolin-7-O-ß-D-glucoside inhibits cellular energy production interacting with HEK2 in keratinocytes 165
Effects of topical 0.8% piroxicam and 50+ sunscreen filters on actinic keratosis in hypertensive patients treated with or without photosensitizing diuretic drugs: an observational cohort study 161
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: preliminary results on metabolic biomarkers 154
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis 147
Lactoferrin as Protective Natural Barrier of Respiratory and Intestinal Mucosa against Coronavirus Infection and Inflammation 147
Dermoscopic Analysis of 72 “Atypical” Seborrheic Keratoses|Análisis dermatoscópico de 72 queratosis seborreicas «atípicas» 143
Totale 31.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.184
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.184
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.621 0 0 0 0 796 940 845 845 970 869 647 709
2020/20217.367 682 739 660 878 1.031 861 991 779 165 250 203 128
2021/20221.791 95 184 86 75 77 160 140 90 131 140 123 490
2022/20232.221 230 260 73 244 213 501 197 117 191 27 115 53
2023/20241.145 108 34 69 34 80 212 128 71 24 86 105 194
2024/20252.217 166 1.053 599 330 69 0 0 0 0 0 0 0
Totale 37.672